EUVIMEDEUVIMED entdecken
Crossref

Garcinol as A Promising Therapeutic Candidate for Alzheimer's Disease: Integrated Computational and In Vitro Target Analysis

Abhishek Mishra, Bhabani Sankar Satapathy, Srikanth Gatadi, Malkhed Vasavi, Pratap Kumar Sahu, Vijay Nuthakki

ChemistrySelect · 2025-07 · 10 (25)

DOI: 10.1002/slct.202501371 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemistrySelect, online erschienen am 04.07.2025. Verfasst von Abhishek Mishra und 5 weiteren Autor:innen. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 76 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Garcinol (GL) exhibits profound antioxidant and anti‐inflammatory properties, contributing to its promising neuroprotective action. Recent reports disseminate the capacity of GL to influence neuronal growth and survival, altering the neurochemical status in the brain and regulating memory and cognition. Thus, the concomitant neuro‐rescue property of garcinol may render it an effective therapeutics in Alzheimer's disease (AD). Emerging data relating histone acetylation abnormalities to the course of neurodegenerative disorders provides an effective basis to explore GL as an anti‐AD therapeutic. The present study aims to unveil the anti‐AD potentiality of GL through a comprehensive in silico approach involving ADMET screening, molecular docking, and molecular dynamic simulation analysis supported by in vitro analysis. ADMET analysis demonstrated higher bioavailability and lower GL toxicity. High binding affinity (> 10) of GL with key anti‐AD mediators was predicted from molecular docking study. Also, molecular dynamic simulation proves GL could fit into the 6IYC binding pocket with favorable and stable ligand‐protein interactions. In vitro DPPH analysis revealed excellent antioxidant potency of GL. MTT data showed the non‐toxic nature of GL on healthy brain cells. Outcome of the study would be helpful in futuristic studies of GL to establish it as a potent drug candidate in AD.

Zitieren

APA

Mishra, A., Satapathy, B. S., Gatadi, S., Vasavi, M., Sahu, P. K., & Nuthakki, V. (2025). Garcinol as A Promising Therapeutic Candidate for Alzheimer's Disease: Integrated Computational and In Vitro Target Analysis. ChemistrySelect, 10(25). https://doi.org/10.1002/slct.202501371

Vancouver

Mishra A, Satapathy BS, Gatadi S, Vasavi M, Sahu PK, Nuthakki V. Garcinol as A Promising Therapeutic Candidate for Alzheimer's Disease: Integrated Computational and In Vitro Target Analysis. ChemistrySelect. 2025;10(25). doi:10.1002/slct.202501371

BibTeX
@article{Mishra2025,
  author = {Mishra, Abhishek and Satapathy, Bhabani Sankar and Gatadi, Srikanth and Vasavi, Malkhed and Sahu, Pratap Kumar and Nuthakki, Vijay},
  title = {Garcinol as A Promising Therapeutic Candidate for Alzheimer's Disease: Integrated Computational and In Vitro Target Analysis},
  journal = {ChemistrySelect},
  year = {2025},
  volume = {10},
  number = {25},
  doi = {10.1002/slct.202501371}
}
Kostenlos starten →